Infinimmune website screenshot

Infinimmune

Infinimmune is a biotechnology company that discovers and engineers human-derived antibody therapeutics. Its Complete Human Sequencing and Anthrobody library-on-B-cell platform surface rare antibodies that evolution has already proven in people, and its GLIMPSE antibody language model characterizes and optimizes candidates in silico for clinical development. Its lead program, IFX-101, is an IL-22 inhibitor for moderate-to-severe atopic dermatitis, with additional pipeline programs targeting IL-13, APRIL, and IL-17F. Backed by Playground Global. Infinimmune publishes no public developer API, SDKs, or machine-readable specifications; this API Evangelist profile captures the company identity and its public web, security, and legal surface.

Infinimmune is profiled on the APIs.io network. Tagged areas include Company, Engineered Biology, Biotechnology, Antibody Discovery, and Therapeutics.

Infinimmune’s developer surface includes engineering blog and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub
9.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyEngineered BiologyBiotechnologyAntibody DiscoveryTherapeuticsDrug DiscoveryMachine Learning

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 9.3/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/infinimmune: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Infinimmune Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 3

The organization behind the API

Website
Website
 Blog
Blog
 LinkedIn
LinkedIn

Source (apis.yml)

apis.yml Raw ↑ 
aid: infinimmune
name: Infinimmune
description: Infinimmune is a biotechnology company that discovers and engineers human-derived antibody therapeutics. Its
  Complete Human Sequencing and Anthrobody library-on-B-cell platform surface rare antibodies that evolution has already proven
  in people, and its GLIMPSE antibody language model characterizes and optimizes candidates in silico for clinical development.
  Its lead program, IFX-101, is an IL-22 inhibitor for moderate-to-severe atopic dermatitis, with additional pipeline programs
  targeting IL-13, APRIL, and IL-17F. Backed by Playground Global. Infinimmune publishes no public developer API, SDKs, or
  machine-readable specifications; this API Evangelist profile captures the company identity and its public web, security,
  and legal surface.
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://cdn.prod.website-files.com/690cad571d73e7d22fcd17e0/691fb88457f315754d06806d_0537e5d67857b8b6b32813b7197f4784_Frame%201597880071.png
url: https://raw.githubusercontent.com/api-evangelist/infinimmune/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- playground-global
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Engineered Biology
- Biotechnology
- Antibody Discovery
- Therapeutics
- Drug Discovery
- Machine Learning
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/infinimmune-domain-security.yml
- type: Website
  url: https://www.infinimmune.com/
- type: Blog
  name: News
  url: https://www.infinimmune.com/news
- type: PrivacyPolicy
  url: https://www.infinimmune.com/privacy-policy
- type: LinkedIn
  url: https://www.linkedin.com/company/infinimmune
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence